Insider Transactions in Q3 2022 at Frequency Therapeutics, Inc. (FREQ)
Insider Transaction List (Q3 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jul 06
2022
|
Richard J. Mitrano VP Finance & Operations |
SELL
Open market or private sale
|
Direct |
2,184
-6.58%
|
$2,184
$1.54 P/Share
|
|
Jul 06
2022
|
Christopher R. Loose Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
4,415
-8.11%
|
$4,415
$1.53 P/Share
|
|
Jul 06
2022
|
Quentin Mc Cubbin Chief Manufacturing Officer |
SELL
Open market or private sale
|
Direct |
6,569
-14.63%
|
$6,569
$1.52 P/Share
|
|
Jul 06
2022
|
Carl Le Bel Chief Development Officer |
SELL
Open market or private sale
|
Direct |
4,421
-14.37%
|
$4,421
$1.52 P/Share
|
|
Jul 06
2022
|
Wendy S Arnold Chief People Officer |
SELL
Open market or private sale
|
Direct |
5,638
-21.02%
|
$5,638
$1.52 P/Share
|
|
Jul 05
2022
|
Richard J. Mitrano VP Finance & Operations |
BUY
Exercise of conversion of derivative security
|
Direct |
7,500
+18.44%
|
-
|
|
Jul 05
2022
|
Christopher R. Loose Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+21.59%
|
-
|
|
Jul 05
2022
|
Quentin Mc Cubbin Chief Manufacturing Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
17,500
+28.04%
|
-
|
|
Jul 05
2022
|
Carl Le Bel Chief Development Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+32.78%
|
-
|
|
Jul 05
2022
|
Wendy S Arnold Chief People Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+35.86%
|
-
|